Wednesday, Feb. 20

Session II: Concurrent C

Oral Abstract Presentations: Outcomes

9:10–10:40 a.m.

Larry Goldstein, M.D., Durham, North Carolina

Karen Johnston, M.D., M.S ., Charlottesville, Virginia

9:10 – Long-Term Prognosis After Transient Ischemic Attack (TIA)  8

Anthony S. Kim, UCSF, San Francisco, CA; Stephen Sidney, Div of Res, Kaiser Permanente Northern California, Oakland, CA; Allan L. Bernstein, Kaiser Santa Rosa Medical Ctr, Santa Rosa, CA; S. Claiborne Johnston, UCSF, San Francisco, CA

9:22 – Low-income, Low-hospital Volume and High Stroke Mortality: The Puzzling Route Of Inequity   9

Gustavo Saposnik, Univ of Toronto, Toronto, ON, Canada; Thomas Jeerakathil, Univ of Alberta, Edmonton, AB, Canada; Daniel Selchen, Univ of Toronto, Missassauga, ON, Canada; Vladimir Hachinski, Univ of Western Ontario, London, ON, Canada; Moira K Kapral, Univ of Toronto, Toronto, ON, Canada; on behalf of the Stroke Outcome Research Canada (SORCan) Working Group

9:34 – Does Stroke Patient’s Weight Influence the Response to Intravenous t-PA?    10

Min Lou, The 2nd Affiliated Hosp of Zhejiang Univ, Hangzhou, China; Magdy H Selim, Beth Israel Deaconess Medical Ctr, Boston, MA

9:46 – Chronic Kidney Disease is a Strong Independent Predictor of Poor Outcome in Patients With Acute Stroke    11

Gilad Yahalom, Roseline Schwartz, Yvonne Schwammenthal, Oleg Merzeliak, Maya Toashi, David Orion, David Tanne, Chaim Sheba Medical Ctr, Tel-Hashomer, Israel

9:58 – The Impact of Case Managed Care in Patients with Acute Stroke and Transient Ischemic Attack    12

Annette C Robertson, Jiming Fang, Inst for Clinical Evaluative Sciences, Toronto, ON, Canada; M Patrice Lindsay, Canadian Stroke Network, Ottawa, ON, Canada; Moira K Kapral, Frank L Silver, Univ of Toronto, Toronto, ON, Canada

10:10 – Long-term Use of Secondary Stroke Prevention Therapies Among US Veterans    13

Thursday, February 21

Session VI: Concurrent Symposia C

Cost-effectiveness Studies in Stroke

7:30–9:00 a.m.

S. Claiborne C. Johnston, M.D., San Francisco, Calif.

Lewis B. Morgenstern, M.D., Ann Arbor, Mich.

7:30 – Projected Cost of Stroke

Devin L. Brown, M.D., M.S., FAHA, Ann Arbor, Mich.

7:45 – How to Incorporate Cost-effectiveness Analysis in Clinical Trials

David Matchar, M.D, FAHA, FACP, Durham, NC

8:00 – Pharmacoeconomics of Stroke Treatment

Susan C. Fagan, Pharm.D., FAHA, Augusta, GA

8:15 – How to Interpret Cost-effectiveness Data in Clinical Practice

Robert Holloway, Jr., M.D., M.P.H., Rochester, NY

8:30 – Discussion

Session VI: Concurrent D

Oral Abstract Presentations: Experimental Ischemia II

7:30–9:00 a.m.

Jun Chen, M.D., Pittsburgh, PA

Marilyn Cipolla, Ph.D., M.S., Burlington, VT

7:30 – Chronic Intermittent Mild Hypoglycemic Episodes Exacerbate Ischemic Damage In Streptozotocin-induced Diabetic Rats    50

7:42 – Intracarotid Delivery of CD49d FACS Sorted Neural Stem Cells Enhances Angiogenesis and Improves Functional Outcome After Experimental Stroke    51

Raphael Guzman, Alejandro De Los Angeles, Kevin Choo, Xavier Gaeta, Joey Cote, Samuel Cheshier, Gary K Steinberg, Stanford Univ, Palo Alto, CA

7:54 – Sex Differences in micro-RNA Expression in Cerebral Ischemia    52

Chad Siegel, Fudong Liu, Louise D McCullough, Univ Connecticut Health Ctr, Farmington, CT

8:06 – The Role of Toll-Like Recptor(TLR) Signaling in Ischemic Precconditioning    53

Bolanle M Famakin, Yongshan Mou, Ryo Ohtani, Christl A Ruetzler, John M Hallenbeck, Natl Insts, Bethesda, MD

8:18 – Chronic Soluble Epoxide Inhibition is Protective Against Cerebral Ischemia During Hypertension    54

Alexis N Simpkins, R Daniel Rudic, David Stepp, Derek A Schreihofer, Siddhartha Roy, Medical Coll of Georgia, Augusta, GA; Bruce D Hammock, Univ of California, Davis, CA; John D Imig, Medical Coll of Georgia, Augusta, GA

8:30 – Extended Timewindow for Neuroprotection by Thiazolidinediones Is Dependent On Time of Reperfusion    55

Jorge Gamboa, Univ of Kentucky, Lexington, OH; Nicole Victor, Gary Landreth, Sophia Sundararajan, Case Western Reserve Univ, Cleveland, OH

8:42 – HSP27 Protects Against Neuronal Ischemia via Attenuation of Mitochondrial Signaling Pathways    56

R Anne Stetler, Guodong Cao, Zhongfang Wang, Feng Zhang, Univ of Pittsburgh, Pittsburgh, PA; Yanqin Gao, Fudan Univ, Shanghai, China; Jun Chen, Univ of Pittsburgh, Pittsburgh, PA

8:54 – Discussion

Session IX: Concurrent D

Oral Abstract Presentations: Nursing and Rehabilitation Professions

2:00–3:30 p.m.

Susan E. Wehner, M.S.N., N.P., Lansing, MI

2:00 – Neuroanatomical Basis of Swallowing Disorders After Stroke    85

Marlis Gonzalez-Fernandez, Jonathan T Kleinman, Paul Ky, Jeffrey B Palmer, Argye E Hillis, Johns Hopkins Univ Sch of Med, Baltimore, MD

2:12 – The Plasticity of Swallowing Center in the Brain    86

Jing Zhang, Xingquan Zhao, Chunxue Wang, Yongjun Wang, BeijingTiantan Hosp Affiliated to Capital Medical Univ, Beijing, China

2:24 – Femoral Artery Blood Flow Velocity and Diameter Changes in the Hemiparetic Limb in Chronic Stroke    87

Sandra A Billinger, Benjamin Y Tseng, Patricia M Kluding, Univ of Kansas Medical Ctr, Kansas City, KS

2:36 – One Year Follow-up Of Patients Who Are Using The Ness L300 Neuroprosthesis: Effects On Gait Performance    88

Gad Alon, Univ of Maryland, Sch of M, Baltimore, MD; Jeffery M Hausdorff, Harvard Medical Sch, Boston, MA; Haim Ring, Sackler Faculty of Med, Tel-Aviv Univ, Tel-Aviv, Israel

2:48 – Efficacious Affected Arm Rehabilitation Via the Internet; Using Inexpensive, Remote Technology to Deliver Electrical Stimulation    89

Stephen Page, Valerie Hill, Peter Levine, Univ of Cincinnati, Cincinnati, OH; Amanda Herzog, Rachel Jordan, Maura Hoefner, Xavier Univ, Cincinnati, OH

3:00 – Stroke Caregiver Outcomes from the Telephone Assessment and Skill-Building Kit (TASK)    90

Tamilyn Bakas, Indiana Univ Sch of Nursing, Indianapolis, IN; Carol J. Farran, Rush Univ Sch of Nursing, Chicago, IL; Joan K Austin, Indiana Univ Sch of Nursing, Indianapolis, IN; Barbara A. Given, Michigan State Univ Coll of Nursing, East Lansing, MI; Susan M. Perkins, Indiana Univ Sch of Med, Indianapolis, IN; Elizabeth A. Johnson, Indiana Univ Sch of Nursing, Indianapolis, IN; Linda S. Williams, Indiana Univ Sch of Med; Regenstrief Inst; Roudebush Veterans Admin Medical Ctr, Indianapolis, IN

3:12 – Costs and Rehabilitation Utilization of Stroke Patients: A Retrospective Study of Medicare Beneficiaries    91

Richard D Zorowitz, Johns Hopkins Bayview Medical Ctr, Baltimore, MD; Er Chen, Kuo B Tong, Quorum Consulting, Inc., San Francisco, CA

3:24 – Discussion

Session IX: Concurrent E

Oral Abstract Presentations: Community/Risk Factors

2:00–3:30 p.m.

Robert Adams, M.D., Charleston, SC

Karen Furie, M.D., FAHA, Boston, MA

2:00 – Insulin Resistance and Risk of Ischemic Stroke Among Non-Diabetic Individuals from the Northern Manhattan Study    92

Tatjana Rundek, Dept of Neurology, Miller Sch of Med, Univ of Miami, Miami, FL; Qiang Xu, Dept of Biostatistics, Joseph Miallman Sch of Public Health, Columbia Univ, New York, NY; Ronald B. Goldberg, Dept of Med, Miller Sch of Med, Univ of Miami, Miami, FL; Bernadette Boden-Albala, Dept of Neurology and Sociomedical Sciences, Mailman Sch of Public Health, Columbia Univ, New York, NY; Norbelina Disla, Dept of Neurology, Columbia Univ, New York, NY; Myunghee C. Paik, Dept of Biostatistics, Joseph Mailman Sch of Public Health, Columbia Univ, New York, NY; Mitchell S. Elkind, Dept of Neurology, Columbia Univ, New York, NY; Ralph L. Sacco, Dept of Neurology, Epidemiology and Human Genetics, Miller Sch of Med, Univ of Miami, Miami, FL

2:12 – C-Reactive Protein Predicts Recurrent Stroke and Death in a Hyperhomocyst(e)inemic Population    93

Karen L Furie, Massachusetts General Hosp, Boston, MA; Annie G. Howard, Lloyd E. Chambless, Stephen Campbell, Univ of North Carolina at Chapel Hill, Chapel Hill, NC; James F. Toole, Wake Forest Univ, Winston-Salem, NC; Mitchell S. Elkind, Columbia Univ, NY

2:24 – Daytime Sleepiness and Risk of Stroke and Vascular Disease: Findings from the Northern Manhattan Study (NOMAS)    94

Bernadette Boden-Albala, Carl Bazil, Yeseon Moon, Janet De Rosa, Mitchell S Elkind, Myunghee C Paik, Columbia Univ, New York, NY; Ralph L Sacco, Universoty of Miami, Miami, FL

2:36 – Stroke in Women - Gender Differences in Stroke Incidence and Post-stroke Disability in the Framingham Heart Study    95

Rodica E. Petrea, Dept of Neurology, Boston Univ Sch of Med, Boston, MA; Alexa S. Beiser, Sudha Seshadri, Margaret Kelly-Hayes, Carlos S. Kase, Philip A. Wolf, Dept of Neurology, Boston Univ Sch of Med, Public Health and Framingham Heart Study, Boston, MA

2:48 – National Utilization of, and Outcomes following, Craniectomy for Space Occupying Cerebral Infarction in the United Statesy    96

Mustapha A Ezzeddine, Zeenat Qureshi Stroke Res Ctr, Univ of Minnesota, Minneapolis, MN; Praveen R Baimeedi, Dept of Neurosurgery, Univ of Minnesota, Minneapolis, MN; Abu Nasar, M. Fareed K Suri, Adnan I Qureshi, Zeenat Qureshi Stroke Res Ctr, Univ of Minnesota, Minneapolis, MN

3:00 – Gene Variants Previously Associated With Coronary Heart Disease: Association With Incident Ischemic Stroke in the Cardiovascular Health Study    97

May M. Luke, CELERA, Alameda, CA; Ellen S. O'Meara, Univ of Washington, Seattle, WA; Charles M. Rowland, Lance A. Bare, Dov Shiffman, CELERA, Alameda, CA; Thomas Lumley, Kenneth Rice, Univ of Washington, Seattle, WA; Andre R. Arellano, CELERA, Alameda, CA; Russell P. Tracy, Univ of Vermont, Colchester, VT; James J. Devlin, CELERA, Alameda, CA; Bruce M. Psaty, Univ of Washington, Seattle, WA

3:12 – Analysis of the Age-at-Onset Phenotype in a Pilot Genome-Wide Association Study of Ischemic Stroke    98

Bradford B Worrall, Univ of Virginia, Charlottesville, VA; W Mark Brown, Wake Forest Sch of Med, Winston-Salem, NC; Thomas G Brott, Mayo Clinic, Jacksonville, FL; Robert D Brown Jr, Mayo Clinic, Rochester, MN; John Hardy, Queen Square, London, United Kingdom; Mar Matarin, Natl Inst of Aging, Bethesda, MD; Stephen S Rich, Univ of Virginia, Charlottesville, VA; Andrew Singleton, Natl Inst of Aging, Bethesda, MD; James F Meschia, Mayo Clinic, Jacksonville, FL; for the Ischemic Stroke Genetics Study (ISGS) Investigators

3:24 – Discussion

Session X: Concurrent Symposia B

Stroke and the Law: Legal Issues in Cerebrovascular Disease

4:00–5:30 p.m.

Mark Fisher, M.D., FAHA, Irvine, CA

Thomas Brott, M.D., Jacksonville, FL

4:00 – Principles of Legal Medicine

Mark Fisher, M.D., FAHA, Irvine, CA

4:20 – Review of Stroke Case Law

Michael I. Weintraub, M.D., Valhalla, NY

4:40 – The Impact of New Stroke Evaluation and Treatment on Litigation

John P. Conomy, M.D., Chagrin Falls, OH

5:00 – The Impact of Medical Legal Issues on Stroke Treatment

Patrick Lyden, MD, FAAN, San Diego, CA

5:20 – Discussion

Session X: Concurrent C

Oral Abstract Presentations: Extracranial Occlusive Disease

4:00–5:30 p.m.

Brian Hoh, M.D., Gainesville, FL

Avery Evans, Charlottesville, VA

4:00 – Timing and Type of Neurologic Events prior to Carotid Artery Stenting are Predictors of Stroke    99

Seemant Chaturvedi, Wayne State Univ, Detroit, MI; Richard Atkinson, Sutter Health, Sacramento, CA; for the CAPTURE and EXACT Executive Committees

4:12 – Neuropsychological Changes After Carotid Stenting With Cerebral Protection    100

Francisco Moniche, Paloma Gonzalez-Perez, Myrta O'Valle, Jose Ramon Gonzalez-Marcos, Alejandro Gonzalez, Aurelio Cayuela, Antonio Mayol, Alberto Gil-Peralta, Hosp. Univ. Virgen del Rocio, Seville, Spain

4:24 – High Volume Centers Have Lower Complication Rates After Cea And Cas In The Space Study    101

Peter A Ringleb, Univ clinic of Heidelberg, Heidelberg, Germany; H. H. Eckstein, Clinic Rechts der Isar, Munich, Germany; Marius Hartmann, Werner Hacke, Univ clinic of Heidelberg, Heidelberg, Germany; SPACE Investigators

4:36 – Extension Of Atherothrombotic Disease To Extracerebral Territories Following Stroke: Inflammation Or Vascular Remodeling Mechanisms?    102

Tomás Sobrino, Miguel Blanco, Dept of Neurology, Clinical Neuroscience Res Lab, Hosp Clínico Univrio, Univ of Santiago de Compostela, Santiago de Compostela, Spain; Joan Montaner, Neurovascular Res Lab, Neurovascular Unit, Vall d'Hebron Univ Hosp, Barcelona, Spain; María Mar Freijó, Dept of Neurology, Hosp de Basurto, Bilbao, Spain; Miguel Angel Llaneza, Dept of Neurology, Hosp Clínico Univrio de Salamanca, Salamanca, Spain; Enrique Corredera, Dept of Neurology, Hosp Meixoeiro, Vigo, Spain; Blanca Fuentes, Dept of Neurology, Hosp Univrio La Paz, Madrid, Spain; Javier Tejada, Dept of Neurology, Hosp de León, León, Spain; David Cánovas, Dept of Neurology, Consorci Hospari del Parc Taulí, Barcelona, Spain; José Castillo, Dept of Neurology, Clinical Neuroscience Res Lab, Hosp Clínico Univrio, Univ of Santiago de Compostela, Santiago de Compostela, Spain; for the MITICO Study Investigators

4:48 -- Inflammatory Markers Predicts Future Cardiovascular and Neurological Events In Patient Undergoing Carotid Stent Implantation    103

Francesco Versaci, Costantino Del Giudice, Tor Vergata Univ, Roma, Italy; Achille Gaspardone, Sant'Eugenio Hosp, Roma, Italy; Gian Luigi Condorelli, Istituto di Ricovero e Cura a Carattere Scientifico Multimedica, Roma, Italy; Antonio Pellegrino, Alessandro Mauriello, Laura Liberatoscioli, Igino Proietti, Giovanni Simonetti, Claudio Cortese, Luigi Chiariello, Tor Vergata Univ, Roma, Italy

5:00 -- Plaque Characterization by Virtual Histology TM Intravascular Ultrasound Analysis in Symptomatic Internal Carotid Artery Stenosis    104

Shoji Matsumoto, Ichiro Nakahara, Toshio Higashi, Yasushi Iwamuro, Yoshihiko Watanabe, Kenji Takahashi, Tetsuhiro Kikuchi, Mitsushige Ando, Masahiro Takezawa, Masahiro Takezawa, Kokura Memorial Hosp, Kitakyushu-shi ,Fukuoka, Japan

5:12 -- High-Resolution CT Imaging of Carotid Artery Atherosclerotic Plaques    105

Max Wintermark, Univ California, San Francisco, CA; Sumayya S Jawadi, Univ of Missouri, Kansas City, KS; Joseph H Rapp, San Francisco VA Medical Ctr, San Francisco, CA; Tarik Tihan, Elizabeth Tong, David Glidden, Univ California, San Francisco, CA; Sami Abedin, Univ of Missouri, Kansas City, KS; Sarah Schaeffer, Gabriel Acevedo-Bolton, Univ California, San Francisco, CA; Benjamin Boudignon, Univ of California, San Francisco, CA; Benjamin Orwoll, Univ California, San Francisco, CA; XianMang Pan, San Francisco VA Medical Ctr, San Francisco, CA; David Saloner, Univ California, San Francisco, CA

5:24 -- Discussion

Session X: Concurrent E

Oral Abstract Presentations: Prevention

4:00–5:30 p.m.

Bruce M. Coull, M.D., FAHA, Tucson, Ariz.

Cathy A. Sila, M.D., FAHA, Cleveland, Ohio

4:00 -- Gender Differences In The Management Of Cerebrovascular Disease: The Challenge Of Secondary Prevention    113

Gustavo Saposnik, Univ of Toronto and Mobility Program Clinical Res Unit, Toronto, ON, Canada; Andrew Yan, Univ of Toronto and Canadian Heart Res Ctr, Toronto, ON, Canada; Amparo Casanova, Canadian Heart Res Ctr, Toronto, ON, Canada; Anatoly Langer, Univ of Toronto and Canadian Heart Res Ctr, Toronto, ON, Canada; Shaun Goodman, Univ of Toronto and Canadian Heart Res Ctr, Toronto, ON, Canada; for the Stroke Outcome Research Canada (SORCan) Working Group

4:12 -- Does Differential Prophylactic Aspirin Use Contribute to Racial and Geographic Disparities in Stroke?    114

Stephen P Glasser, Univ of Alabama Birmingham, Birmingham, AL; Mary Cushman, Univ of Vermont, Burlington, VT; Ronald J Prineas, Wake Forest Univ, Winston-Salem, NC; Dawn Kleindorfer, Univ of Cincinnati Coll of Med, Cincinnati, OH; Valerie Prince, Samford Univ McWhorter Sch of Pharmacy, Birmingham, AL; Zhiying You, Virginia J Howard, George Howard, Univ of Alabama Birmingham, Birmingham, AL; for the REGARDS Investigators

4:24 -- Adherence eValuation After Ischemic stroke Longitudinal (AVAIL): Identifying Facilitators of Adherence to Stroke Prevention Medications    115

Cheryl Bushnell, Wake Forest Univ Health Sciences, Winston-Salem, NC; Mark Alberts, Northwestern Univ, Chicago, IL; Michael Frankel, Emory Univ, Atlanta, GA; Larry B Goldstein, Duke Univ, Durham, NC; Philip Gorelick, Univ of Illinois at Chicago, Chicago, IL; S. Claiborne Johnston, Univ of California at San Francisco, San Francisco, CA; Chelsea Kidwell, Georgetown Univ, Washington, DC; Lee Schwamm, Harvard Univ, Boston, MA; Linda Williams, Indiana Univ, Indianapolis, IN; Eric Peterson, Duke Univ, Durham, NC

4:36 -- Atorvastatin is Similarly Effective in All Ischemic Stroke Subtypes: Secondary Analysis of the SPARCL Trial    116

Pierre Amarenco, Denis Diderot Univ, Paris, France; Oscar Benavente, Univ of Texas Health Science Ctr, San Antonio, TX; Larry B Goldstein, Duke Univ Medical Ctr, Durham, NC; Alfred Callahan III, Saint Thomas Hosp, Nashville, TN; Michael G Hennerici, Univ Heidelberg, Mannheim, Germany; Henrik Sillesen, Univ of Copenhagen, Copenhagen, Denmark; K Michael Welch, Rosalind Franklin Univ of Med and Science, Chicago, IL; Justin Zivin, Univ of California, San Diego, San Diego, CA; on behalf of the SPARCL Investigators

4:48 -- Assessing the Net Clinical Benefit of Warfarin by Ischemic Stroke Risk in Atrial Fibrillation: The ATRIA Study    117

Daniel E Singer, Yuchiao Chang, Massachusetts General Hosp, Boston, MA; Margaret C Fang, Univ of California, San Francisco, CA; Leila H Borowsky, Massachusetts General Hosp, Boston, MA; Niela K Pomernacki, Natalia Udaltsova, Alan S Go, Kaiser Permanente of Northern California Div of Res, Oakland, CA

5:00 -- Closure of the Lead-in Phase of CREST (Carotid Revascularization Endarterectomy Vs. Stenting Trial): 30-day And One Year Analyses    118

Robert W Hobson II, Univ. Med & Dentistry of New Jersey/ NJ Medical Sch, Newark, NJ; Thomas G. Brott, Mayo Clinic, Jacksonville, FL; Gary S. Roubin, Krishna Kathir, Lenox Hill, New York, NY; Alice J. Sheffet, Univ. Med & Dentistry of New Jersey/ NJ Medical Sch, Newark, NJ; Pierre Leimgruber, Deaconess Medical Ctr, Spokane, WA; Christopher White, Ochsner Clinic, New Orleans, LA; Munier Nazzal, Univ of Toledo, Toledo, OH; Elie Chakhtoura, St. Michael's Medical Ctr, Newark, NJ; B. K. Lal, Univ. of Med & Dentistry of New Jersey/ NJ Medical Sch, Newark, NJ; MeeLee Tom, Susan E. Hughes, Univ. Med & Dentistry of New Jersey/ NJ Medical Sch, Newark, NJ; Mary Longbottom, Mayo Clinic, Jacksonville, FL; George Howard, Univ. of Alabama at Birmingham, Birmingham, AL; Stephanie Martin, Univ. of Alabama at Brimingham, Birmingham, AL; Jenifer H Voeks, Univ. of Alabama at Birmingham, Birmingham, AL

5:12 -- Cardiorespiratory Fitness as a Predictor of Fatal and Nonfatal Stroke in Asymptomatic Women and Men    119

Steven P. Hooker, Prevention Res Ctr, Univ of South Carolina, Columbia, SC; Xuemei Sui, Dept of Exercise Science, Univ of South Carolina, Columbia, SC; Natalie Colabianchi, Dept of Epidemiology and Biostatistics and Prevention Res Ctr, Univ of South Carolina, Columbia, SC; John Vena, James Laditka, Dept of Epidemiology and Biostatistics, Univ of South Carolina, Columbia, SC; Michael J. LaMonte, Dept of Social and Preventive Med, Univ at Buffalo, Buffalo, NY; Steven N. Blair, Depts of Exercise Science and Epidemiology and Biostatistics, Univ of South Carolina, Columbia, SC

5:24 -- Discussion

Friday, February 22

Session XI: Concurrent E

Oral Abstract Presentations: Pathophysiology/Thrombosis

8:10–9:40 a.m.

Bruce M. Coull, M.D., FAHA Tucson, Ariz.

Alastair Buchan, M.D., FAHA Oxford, United Kingdom

8:10 -- Elevated Levels of Thrombin-Antithrombin (TAT) are Associated with Greater Stroke Severity in African American but not White Women    134

Cheryl Bushnell, Wake Forest Univ Health Sciences, Winston-Salem, NC; Thomas Ortel, Larry Goldstein, Duke Univ, Durham, NC

8:22 -- Higher Inflammatory Status in Patients with Posterior Circulation Stroke than in Those with Anterior Circulation Stroke    135

A-Hyun Cho, Catholic Univ, St.Mary's Hosp, Seoul, Republic of Korea; Sang Beom Jeon, Hyun-Sook Chi, Seongsoo Jang, Young-Uk Cho, Eugene Lee, Jong S. Kim, Asan Medical Ctr, Seoul, Republic of Korea

8:34 -- Cerebral Autoregulation And CO2 Reactivity In Small Vessel Disease Is Affected By Blood Pressure And Not By White Matter Disease Load    136

Jonathan Birns, King's Coll London Sch of Med, London, United Kingdom; Jozef Jarosz, King's Coll Hosp, London, United Kingdom; Hugh Markus, St George's, Univ of London, London, United Kingdom; Lalit Kalra, King's Coll London Sch of Med, London, United Kingdom

8:46 -- Vulnerability Of Infratentorial White Matter To Nocturnal Decreases In Blood Pressure    137

Jonathan Birns, King's Coll London Sch of Med, London, United Kingdom; Jozef Jarosz, King's Coll Hosp, London, United Kingdom; Hugh Markus, St George's, Univ of London, London, United Kingdom; Lalit Kalra, King's Coll London Sch of Med, London, United Kingdom

8:58 -- Magnitude And Time Course Of Platelet Inhibition With Extended Release Dipyridamole With Or Without Aspirin In Healthy Japanese Volunteers: The Japanese Aggrenox Versus Aspirin Therapy Evaluation (JAGATE)    138

Victor L Serebruany, Alex Malinin, Osler Medical Ctr, Towson, MD; Dan Hanley, Johns Hopkins Univ, Baltimore, MD

9:10 -- Albumin Treatment Improves Microvascular Hemodynamics and Augments the Effect of Thrombolytic Therapy in Arteriolar Thrombosis: a Two-Photon Microscopy Study    139

Myron D. Ginsberg, Hee-Pyoung Park, Anitha Nimmagadda, Richard A. DeFazio, Raul Busto, Ricardo Prado, Univ Miami Sch of Med, Miami, FLD

9:22 -- Scanning Electron Microscopy Analysis of Thromboembolic Material Retrieved from Cerebral and Cervical Arteries of Patients with Acute Ischemic Stroke    140

Raul G Nogueira, Massachusetts General Hosp, Boston, MA; Sivaprasad Sukavaneshvar, Medical Device Evaluation Ctr, Salt Lake City, UT; James D Rabinov, Guilherme Dabus, Albert J Yoo, Ferdinando S Buonanno, Johnny C Pryor, Lee H Schwamm, Joshua A Hirsch, Massachusetts General Hosp, Boston, MA

9:34 -- Discussion